CENCORA, INC. (COR) FY2025 YTD Q3 P&L / Income Statement

Revenue by Business Segment

2024-10-01 to 2025-06-30

Swipe to see the full flow
CENCORA, INC. (COR) FY2025 YTD Q3 P&L / Income StatementIncome statement for 2024-10-01 through 2025-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.SOURCESREVENUE RECONCILIATIONREVENUEGROSSOPERATINGPRE-TAXNETU.S. Healthcare SolutionsInternational Healthcare SolutionsRevenueRevenue before reconciliation (calculated)Intersegment eliminationsGross profitCost of goods soldOperating incomeOperating expenses (calculated)Income before income taxesOther income (expense), net (calculated)Net incomeIncome tax expenseRevenue before reconciliation (calculated)Revenue beforereconciliation(calculated)$237.61 BRevenueRevenue$237.60 BGross profitGross profit$8.52 BOperating incomeOperating income$2.61 BIncome before income taxesPretax income$2.45 BNet incomeNet income$1.90 BOperating expenses (calculated)Operating expenses(calculated)$5.91 BCost of goods soldCost of goods sold$229.08 BIncome tax expenseIncome tax expense$544.50 MOther income (expense), net (calculated)Other income,net (calculated)−$164.72 MU.S. Healthcare SolutionsU.S. HealthcareSolutions$215.19 BInternational Healthcare SolutionsInternationalHealthcare Solutions$22.42 BIntersegment eliminationsIntersegmenteliminations−$10.59 M
Chart details

CENCORA, INC. (COR) FY2025 YTD Q3 P&L / Income Statement

Income statement for 2024-10-01 through 2025-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Revenue
237,604,265,000 US dollars
Cost of goods sold
229,079,303,000 US dollars
Gross profit
8,524,962,000 US dollars
Operating expenses (calculated)
5,914,864,000 US dollars
Operating income
2,610,098,000 US dollars
Other income (expense), net (calculated)
negative 164,718,000 US dollars
Income before income taxes
2,445,380,000 US dollars
Income tax expense
544,495,000 US dollars
Net income
1,900,885,000 US dollars
U.S. Healthcare Solutions
215,193,522,000 US dollars
International Healthcare Solutions
22,421,335,000 US dollars
Litigation and opioid-related expenses, net
46,263,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
Acquisition-related deal and integration expenses
190,930,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
Restructuring and other expenses
140,390,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
Depreciation
362,655,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
Distribution, selling, and administrative
4,744,976,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
Revenue before reconciliation (calculated)
237,614,857,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
Intersegment eliminations
negative 10,592,000 US dollars. Reported reconciliation to consolidated revenue.
U.S. Healthcare Solutions costs (calculated)
212,491,235,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
International Healthcare Solutions costs (calculated)
21,923,719,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
Reconciling items (calculated)
579,213,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Chart connections

  • Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
  • Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
  • Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
  • Of which attributable to CENCORA, INC.: $1.89 B; to noncontrolling interests: $7.01 M.
CENCORA, INC. (COR) FY2025 YTD Q3 P&L / Income Statement Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Gross margin

3.6%

Gross profit / revenue

Operating margin

1.1%

Operating profit / revenue

Cash conversion

39.0%

Operating cash / net income, same period

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!